Collegium Pharmaceutical, Inc. (COLL)
45.54
-3.24
(-6.64%)
USD |
NASDAQ |
Jan 09, 16:00
45.58
+0.04
(+0.09%)
After-Hours: 20:00
Collegium Pharmaceutical Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 2.657M |
| Intuitive Surgical, Inc. | 329.40M |
| Alnylam Pharmaceuticals, Inc. | 358.81M |
| Corcept Therapeutics, Inc. | 68.85M |
| Altimmune, Inc. | 14.93M |